Status:
COMPLETED
Lessons on Urethral Lidocaine in Urodynamics
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Urethra Issue
Pelvic Organ Prolapse
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong d...
Detailed Description
This trial is a randomized, double blind, controlled trial for patients undergoing complex cystometric evaluation. Patients will undergo routine complex cystometric evaluation for acquisition of basel...
Eligibility Criteria
Inclusion
- Female patients
- \>18 years of age
- Already scheduled (or being scheduled) for UDS to assess urinary incontinence
- Able to speak and read in English
Exclusion
- Diagnosis of pelvic pain, interstitial cystitis, or bladder pain syndrome
- Known neurogenic disease impacting voiding/ continence (e.g., Parkinson disease, multiple sclerosis, myasthenia gravis, recent stroke)
- Active UTI
- Pelvic organ prolapse that is unable to be easily reduced
- Pregnancy or breastfeeding
- Allergy or hypersensitivity to lidocaine or local anesthetics
Key Trial Info
Start Date :
August 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2021
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04038099
Start Date
August 14 2019
End Date
August 18 2021
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390